Abstract
HSCT recipients are at increased risk for COVID-19-associated morbidity and mortality. Early treatment of symptomatic SARS-CoV-2 infection is an impor......
小提示：本篇文献需要登录阅读全文，点击跳转登录
Full Text Link
